HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Senetek

This article was originally published in The Rose Sheet

Executive Summary

Kinetin anti-aging technology manufacturer will add two age-defying technologies to its stable in the next year, Chairman and CEO Frank Massina says at company's annual meeting in San Francisco Nov. 15. Zeatin, an analog of Kinetin, and Kinetin Plus, a product that could combine the ingredient with other anti-aging technologies such as J&J's Renova, are in the pipeline. Revlon and The Body Shop plan to introduce skin care lines containing Kinetin in 2001 (1"The Rose Sheet" June 19, In Brief). Senetek recently cut its work force by 74% and divested its Mill Creek and Allercreme businesses to focus on dermatological and sexual dysfunction products

Latest Headlines
See All
UsernamePublicRestriction

Register

RS008685

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel